When glutathione production drops, you are more vulnerable to developing autoimmune disease, chronic pain, chemical sensitivities, leaky gut and other immune-related disorders
In a 1-month pilot clinical study of oral liposomal GSH administration at doses of 500 mg and 1000 mg per day, researchers recorded impressive systemic improvements [1]
It plays a huge part in creating and regulating our DNA and red blood cells
Tirzepatide, having received FDA approval, has a more defined safety record, though patients should be monitored for potential risks such as pancreatitis or thyroid tumors, which have been concerns with GLP-1 receptor agonists in general
Heat above 25C can also potentially be a problem, although less so